Sharon Pangburn

1.1k citations
8 papers · 854 indexed · h-index 8
Topics
Enzyme Production and Characterization (2 papers)Hydrogels: synthesis, properties, applications (1 paper)RNA modifications and cancer (1 paper)
Partner nations
United States

In The Last Decade

Sharon Pangburn

8 papers receiving 793 citations

Peers

Sharon Pangburn
Comparison fields: 5 of 93
  • Molecular Biology 329
  • Surgery 207
  • Biomaterials 181
  • Endocrinology, Diabetes and Metabolism 109
  • Cancer Research 107
Replace Chi-Chung Wang with:
Chi-Chung Wang Taiwan
Chang Su China
Somnath Singh United States
Chao Zheng China
Giovana R. Onzi Brazil
Davoud Jafari-Gharabaghlou Iran
Wei‐Hao Sun China
Hua Tang China
Edna Mora United States
Yijia Chen China
Sharon Pangburn relative to Chi-Chung Wang Taiwan Chi-Chung Wang's profile →
Citations per field
00.5×6.8×
Chi-Chung Wang · 1×
Citations per year

Countries citing papers authored by Sharon Pangburn

Since Specialization
Citations

This map shows the geographic impact of Sharon Pangburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Pangburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Pangburn more than expected).

Fields of papers citing papers by Sharon Pangburn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Pangburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Pangburn. The network helps show where Sharon Pangburn may publish in the future.

Co-authorship network of co-authors of Sharon Pangburn

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Pangburn. A scholar is included among the top collaborators of Sharon Pangburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Pangburn. Sharon Pangburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 41
2 104
3 226
4 84
5 101
6 215
7 11
8 72

About Sharon Pangburn

Sharon Pangburn is a scholar working on Biotechnology, Pharmaceutical Science and Molecular Medicine, having authored 8 papers that have together received 854 indexed citations. Recurring topics across this work include Enzyme Production and Characterization (2 papers), Hydrogels: synthesis, properties, applications (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Pharmaceutical Science (97 citations), Molecular Medicine (71 citations) and Biomaterials (181 citations). Sharon Pangburn has collaborated with scholars based in United States. Frequent co-authors include J. Heller, Daniel Steinberg, David Weinstein, David R. Friend, Roger J. Davis, Sheldon C. Engelhorn, Christian A. Drevon, Alan Attie, Thomas H. Jukes and Richard Holmquist. Their work appears in journals such as Journal of Biological Chemistry, Biomaterials and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026